Introduction {#Sec1}
============

Female pelvic organ prolapse (POP) is a common condition that is multifactorial in etiology \[[@CR1]\]. It is likely that combinations of anatomical, physiological, genetic, lifestyle, and reproductive factors interact throughout a woman's lifespan to contribute to pelvic floor dysfunction \[[@CR2]\]. The factors causing POP development vary from patient to patient \[[@CR3]\]. Unraveling the complex causal network of genetic factors, birth-induced injury, connective tissue aging, lifestyle, and co-morbid factors is challenging \[[@CR2]\].

While two thirds of parous women have anatomical evidence of POP \[[@CR4]\], the majority of these women are asymptomatic \[[@CR5]\]. It has been reported that in a general population 40 % of women aged between 45 and 85 years have an objective POP on examination, but only 12 % of these women are symptomatic \[[@CR6]\]. Women with symptomatic disorders suffer physical and emotional distress \[[@CR7]\]. It has a great negative impact on women's social, physical, and psychological well-being \[[@CR8]\]. As the general population ages, pelvic floor dysfunction will become increasingly burdensome in terms of reduced quality of life, workforce productivity, and cost to both the individual and the health care system as a whole \[[@CR9]\].

The lifetime risk of surgery for POP in the general female population is 11.1 % \[[@CR10]\]. Surgery for POP is known to have a high reoperation rate \[[@CR10]\]. The identification of risk factors for POP development and its recurrence therefore appears crucial for the best management of women with this condition to provide proper preoperative counseling or modulate patients' expectations and tailor surgical treatment \[[@CR11]\].

An overview of the literature on risk factors for POP and its recurrence after native tissue repair would help to build a risk model to identify low- and high-risk women. The purpose of this systematic review was to provide an overview of the published literature on risk factors for the development of POP and its recurrence after native tissue repair.

Materials and methods {#Sec2}
=====================

The primary investigator (TFMV) and a clinical librarian searched the electronic databases PubMed and Embase with the search terms "pelvic organ prolapse" in combination with "recurrence," and "pelvic organ prolapse" in combination with "risk factors" from inception until 4 August 2014. To capture all relevant articles on this subject, Medical Subject Headings (MeSH) and Thesaurus terms and text words with different word variations were used. Restrictions on publication date or language were not applied. The searches are depicted in the Appendices [A1](#Sec15){ref-type="sec"} and [A2](#Sec16){ref-type="sec"}.

At first, all studies were evaluated by title. Of the papers available, those titles were selected that might contain information about risk factors for primary POP or POP recurrence.

After this preselection, two researchers (TFMV and MW) independently evaluated all studies by abstract. If there was disagreement, full-text articles were evaluated. If the full text was unavailable, authors were contacted to obtain the article. Abstracts were included in case they reported on clinical studies on the etiology or risk factors for primary POP or POP recurrence. Letters, commentaries, and editorial notes were excluded. The full text of the articles included was assessed using an in- and exclusion form. Cohort studies or cross-sectional studies carried out in western developed countries were included. The definition of POP had to be based on anatomical references such as the hymenal remnants or the Pelvic Organ Prolapse Quantification (POPQ) system stage 2. POP recurrence had to be defined as anatomical recurrence after native tissue repair (i.e., without the use of mesh materials and follow-up after surgery should at least be 1 year. Furthermore, articles had to contain a multivariate analysis. Articles were excluded if they did not study POP as a separate entity (but investigated pelvic floor dysfunction in general), if it was unclear whether the outcome was a primary POP or a POP recurrence (e.g., after hysterectomy) and in case POP recurrence was studied after mesh augmentation. If there were more publications using the same study population, only the most recent study was included. If there was disagreement on the in- or exclusion of an article after discussion between the two observers, the decision was made by asking the opinion of one of the other researchers in the research group (KBK).

A manual search of the references of each selected article was performed to further identify studies not captured by the online search, but potentially relevant for this review.

After the final selection, data were extracted on study design, the aim of the study, sample size, the study population, the definition of outcome, the risk factors investigated, and the results of the multivariate analysis. If multiple analyses were performed with different definitions of POP, data regarding the definition "POPQ stage 2 or more" or closest to this definition, were extracted.

*P* values \<0.05 were considered statistically significant. Only risk factors that were significantly associated with POP or POP recurrence in the multivariate analysis in at least two studies, were defined as confirmed risk factors.

Results {#Sec3}
=======

The PubMed search and the Embase search revealed 2,988 and 4,449 articles respectively. After elimination of duplicates, 5,093 articles were evaluated by title and/or abstract. Full texts of 130 articles were assessed using the in- and exclusion form, of which 15 articles met the selection criteria. No additional studies were identified by cross-checking reference lists. Of the 15 articles included in this systematic review, 10 investigated risk factors for primary POP and 5 articles investigated risk factors for POP recurrence after surgery. Figure [1](#Fig1){ref-type="fig"} shows the flow diagram of the selection process.Fig. 1Flow diagram of the selection process

Risk factors for primary POP {#Sec4}
----------------------------

The articles investigating potential risk factors for primary POP are listed in Table [1](#Tab1){ref-type="table"}. Of the 10 articles included, 7 were cross-sectional studies and 3 were prospective cohort studies. Overall, the quality of the studies included was assessed as adequate: all studies had clear participant recruitment and selection criteria; the outcome and covariates were clearly defined; the results were well presented; sample sizes were sufficient for the number of predictor variables examined (i.e., more than 10 events per candidate variable) \[[@CR12]\]. In 3 studies it was explicitly described that the examining physician was blinded to other data, such as a questionnaire or ultrasound findings \[[@CR6], [@CR13], [@CR14]\].Table 1The articles on primary prolapse included in the studyReferenceStudy type*N*/*n*Inclusion criteriaRisk factorsProgetto Menopausa Italia Study Group \[[@CR20]\]Cross-sectional study21,449/410Nonhysterectomized women around menopause attending an outpatient menopause clinic for general counselling about menopauseBMI, delivery mode, age, parity, smoking, education, birth weight, age at menarche, age at menopauseNygaard et al \[[@CR15]\]Cross-sectional study270/173Nonhysterectomized women enrolled in the WHI Hormone Replacement Therapy clinical randomized trialBMI, delivery mode, age, smoking, hormone replacement therapy, education, birth weight, waist circumference, occupation, physical activity, family history, age at first and last delivery, pulmonary disease, previous hernia surgerySwift et al \[[@CR13]\]Cross-sectional study1,004/218Women older than 18 years of age presenting for routine gynecological health careBMI, delivery mode, age, parity, smoking, ethnicity, hormone replacement therapy, birth weight, constipation, occupation, hysterectomy status, menopausal status, chronic illness, income, gravidityWhitcomb et al \[[@CR16]\]Cross-sectional study1,137/762Women between 40 and 69 years of age who, since age 18 years, had been members of the Kaiser Permanente Medical Care Program of Northern CaliforniaBMI, age, parity, ethnicity, education, diabetesSlieker-Ten Hove et al \[[@CR6]\]Cross-sectional study649/227A general population of women aged 45 to 85 yearsBMI, age, parity, smoking, menopausal status, education, physical activity, family history, urinary incontinence, prolapse during pregnancyHanda et al \[[@CR17]\]Prospective cohort study1,011/75Women between 15 and 50 years of age giving birth to their first child 5 to 10 years before enrolmentDelivery modeKudish et al \[[@CR21]\]Prospective cohort study12,650/2,266Nonhysterectomized postmenopausal women enrolled in the WHI Estrogen plus Progestin Clinical TrialBMI, age, parity, smoking, ethnicity, hormone replacement therapy, waist circumference, constipation, physical activity, pulmonary disease, urinary incontinenceDietz et al \[[@CR14]\]Cross-sectional study605/NA^a^Women without previous incontinence or prolapse surgery with symptoms of pelvic floor dysfunction, with data of four-dimensional ultrasoundLevator avulsion, hiatal area on ValsalvaGlazener et al \[[@CR18]\]Prospective cohort study762/182Women who delivered over a 12-month period in three maternity unitsBMI, delivery mode, parity, age at first birthYeniel et al \[[@CR19]\]Cross-sectional study1,964/155Women without previous prolapse surgery with benign gynecological disordersBMI, delivery mode, smoking, menopausal status*N*/*n* number of women included in the study who underwent physical examination/number of women with pelvic organ prolapse,*BMI* Body Mass Index in kg/m^2^, WHI Women's Health Initiative, NA not available^a^Number of women categorized by type of prolapse: 222 women with cystocele, 159 women with rectocele, 40 women with apical prolapse

The 10 articles included enrolled a total of 41,501 women. POP was defined as POPQ stage 2 or more in 4 studies \[[@CR6], [@CR14]--[@CR16]\], as the most dependent point of the vaginal wall to or beyond the hymenal remnants in 3 studies \[[@CR17]--[@CR19]\], as degree 2 or 3 of the Baden--Walker classification system in 1 study \[[@CR20]\], as the most dependent point of the vaginal wall to the introitus or outside of the vagina (according to the Women's Health Initiative classification system) in 1 study \[[@CR21]\], and as the most dependent point of the vaginal wall --0.5 cm above the hymenal remnants in 1 study \[[@CR13]\].

In the 10 articles, 30 potential risk factors were investigated, of which 17 were significantly associated with primary POP at least once in the multivariate analysis. Obstetric factors are represented in Table [2](#Tab2){ref-type="table"}. Other potential risk factors are shown in Table [3](#Tab3){ref-type="table"}.Table 2Obstetric risk factors for primary prolapseRisk factorTimes investigatedTimes statistically significant*N*DefinitionAdjusted OR^a^ (95 % CI)ReferenceDelivery mode7521,449≥1 cesarean vs no cesareanOR 0.6 (0.4-1.0)\[[@CR20]\]270Per 1 vaginal deliveryOR 1.6 (1.0-2.5)\*\[[@CR15]\]No vaginal deliveries vs 1 or 2OR 0.0 (0.0--0.4)\*No vaginal deliveries vs 3 or 4OR 0.1 (0.0--0.5)\*No vaginal deliveries vs ≥5OR 0.1 (0.0--0.6)\*3 or 4 vaginal deliveries vs 1 or 2OR 0.7 (0.3--1.7)≥5 vaginal deliveries vs 1 or 2OR 1.2 (0.4--3.4)1,004Per 1 vaginal deliveryOR 1.1 (0.9--1.4)\[[@CR13]\]1,137Cesarean only vs nulliparousPR 1.1 (1.0--1.2)\*\[[@CR16]\]≥1 vaginal delivery vs nulliparousPR 1.1 (1.1--1.2)\*1,011All cesarean before full dilation vs all cesarean before laborRR 0.5 (0.1--2.3)\[[@CR17]\]≥1 cesarean after full dilation vs all cesarean before laborRR 0.7 (0.2--3.1)Spontaneous vaginal births vs all cesarean before laborRR 5.6 (2.2--14.7)\*≥1 operative vaginal birth vs all cesarean before laborRR 7.5 (2.7--20.9)\*726Cesarean only vs spontaneous vaginal delivery onlyOR 0.1 (0.0--0.4)\*\[[@CR18]\]≥1 forceps delivery vs spontaneous vaginal delivery onlyOR 0.6 (0.4--1.0)\*≥1 vacuum extraction, no forceps vs spontaneous vaginal delivery onlyOR 0.7 (0.4--1.4)Vaginal and caesarean deliveries vs spontaneous vaginal delivery onlyOR 0.5 (0.2--1.0)\*1,964Vaginal delivery vs nulliparousOR 2.9 (1.2--7.2)\*\[[@CR19]\]Cesarean vs nulliparousOR 0.3 (0.0--2.5)Parity6421,4491 vs 0OR 3.1 (1.5--6.4)\*\[[@CR20]\]2 vs 0OR 3.4 (1.7--6.7)\*≥3 vs 0OR 4.6 (2.3--9.1)\*1,004Per 1OR 1.1 (0.7--1.7)\[[@CR13]\]6491 vs 0OR 0.4 (0.2--1.2)\[[@CR6]\]2 vs 0OR 1.6 (0.9--2.7)≥3 vs 0OR 1.5 (0.9--2.8)12,6501 vs 0HR 2.4 (1.7--3.6)\*\[[@CR21]\]2 vs 0HR 3.5 (2.5--4.9)\*3 vs 0HR 3.9 (2.8--5.4)\*4 vs 0HR 5.1 (3.7--7.1)\*≥5 vs 0HR 5.9 (4.2--8.1)\*7262 vs 1OR 3.3 (1.5--7.3)\*\[[@CR18]\]3 vs 1OR 3.9 (1.7--9.2)\*≥4 vs 1OR 5.2 (2.0--13.4)\*1,964Per 1OR 1.2 (1.1--1.4)\*\[[@CR19]\]Birth weight3121,449\>4,500 g vs ≤4,500 gOR 1.3 (0.9--1.7)\[[@CR20]\]270\>3,690 g vs ≤3,690 gNS^b^\[[@CR15]\]1,004Per 10 ouncesOR 1.1 (1.0--1.2)\*\[[@CR13]\]Age at first delivery21270\<20 vs 20--24 vs ≥25NS^b^\[[@CR15]\]72625--29 vs ≤24OR 1.5 (0.9--2.3)\[[@CR18]\]30--34 vs ≤24OR 2.5 (1.5--4.2)\*≥35 vs ≤24OR 3.1 (1.4--6.6)\*Age at last delivery10270≤29 vs 30--34 vs ≥35NS^b^\[[@CR15]\]Gravidity101,004Per 1OR 0.9 (0.7--1.2)\[[@CR13]\]*N* number of participants, OR odds ratio, 95 % CI  95 % confidence interval, PR prevalence ratio, RR risk ratio, HR hazard ratio, NS not statistically significant\*Statistically significant association (*p* \< 0.05)^a^In some studies PR, RR or HR was used^b^No other data in articleTable 3Non-obstetric risk factors for primary prolapseRisk factorTimes investigatedTimes significantly different*N*DefinitionAdjusted OR^a^ (95 % CI)ReferenceLifestyle factors  BMI8521,44923.8--27.2 vs \<23.8OR 1.6 (1.2--2.2)\*\[[@CR20]\]\>27.2 vs \<23.8OR 1.8 (1.3--2.4)\*270\<27 vs ≥27NS^b^\[[@CR15]\]1,00425--30 vs \<25OR 2.5 (1.2--5.4)\*\[[@CR13]\]\>30 vs \<25OR 2.6 (1.2--5.4)\*1,13725--30 vs \<25PR 1.1 (1.0--1.1)\*\[[@CR16]\]≥30 vs \<20PR 1.1 (1.0--1.1)\*649Per kg/m^2^NS^b,c^\[[@CR6]\]12,65025--30 vs \<25HR 1.3 (1.1--1.4)\*\[[@CR21]\]≥30 vs \<25HR 1.3 (1.1--1.5)\*726\<18.5 vs 18.5--24.9OR 1.2 (0.3--5.0)\[[@CR18]\]25--29.9 vs 18.5--24.9OR 1.3 (0.9--2.0)≥30 vs 18.5--24.9OR 1.5 (0.9--2.4)1,964Per kg/m^2^OR 1.0 (0.9--1.0)\*\[[@CR19]\]  Smoking6321,449\<10 vs noOR 1.6 (1.0--2.6)\[[@CR20]\]10--20 vs noOR 1.1 (0.6--2.1)\>20 vs noOR 1.3 (0.7--2.4)270UnknownNS^b,c^\[[@CR15]\]1,004Ever vs neverOR 1.2 (0.6--2.4)\[[@CR13]\]Current vs neverOR 0.9 (0.3--2.5)649Current vs noOR 0.5 (0.3--0.8)\*\[[@CR6]\]12,650Past vs neverHR 0.8 (0.7--0.8)\*\[[@CR21]\]Current vs neverHR 0.5 (0.4--0.7)\*1,964Yes vs noOR 0.6 (0.3--0.9)\*\[[@CR19]\]  HRT31270UnknownNS^b,c^\[[@CR15]\]1,004Ever vs neverOR 1.0 (0.6--1.7)\[[@CR13]\]12,650E + P treatment vs placeboHR 1.1 (1.0--1.3)\*\[[@CR21]\]Past hormone use vs neverHR 1.1 (1.0--1.2)Current hormone use vs neverHR 1.2 (1.0--1.5)  Physical activity30270Mild vs moderate vs strenuousNS^b,c^\[[@CR15]\]649Current heavy work vs noOR 1.3 (0.9--2.0)\[[@CR6]\]Past heavy work vs noNS^b,c^12,650UnknownHR 1.0 (1.0--1.0)\[[@CR21]\]  Waist circumference21270\<88 cm vs ≥88 cmNS^b^\[[@CR15]\]12,650\>88 cm vs \<88 cmHR 1.2 (1.0--1.4)\*\[[@CR21]\]Unmodifiable factors  Age6421,44952--55 vs ≤51OR 1.5 (1.1--2.0)\*\[[@CR20]\]≥56 vs ≤51OR 2.6 (2.0--3.4)\*270≥68 vs \<68NS^b,c^\[[@CR15]\]1,004Per 10 yearsOR 1.4 (1.1--1.8)\*\[[@CR13]\]1,137Per 10 yearsPR 1.0 (1.0--1.1)\*\[[@CR16]\]649Per 1 yearNS^b,c^\[[@CR6]\]12,650Per 1 yearHR 1.0 (1.0--1.0)\*\[[@CR21]\]  Ethnicity321,004Black vs whiteOR 1.2 (0.4--3.3)\[[@CR13]\]Hispanic vs whiteOR 4.3 (1.8--10.2)\*Other vs whiteOR 2.4 (0.5--12.1)1,137White vs African--AmericanPR 1.0 (1.0--1.1)\[[@CR16]\]Asian vs African--AmericanPR 1.0 (1.0--1.1)Latina/other vs African--AmericanPR 1.0 (1.0--1.1)12,650Black vs whiteHR 0.5 (0.4--0.7)\*\[[@CR21]\]Hispanic vs whiteHR 0.9 (0.7--1.1)  Menopausal status311,004No vs yesOR 0.6 (0.4--1.1)^c^\[[@CR13]\]649Yes vs noOR 1.3 (0.9--1.9)\[[@CR6]\]1,964Yes vs noOR 5.2 (3.4--8.0)\*\[[@CR19]\]  Family history20270Family with prolapse/UI surgeryNS^b,c^\[[@CR15]\]649Mother with prolapse vs noOR 1.6 (1.0--2.4)\[[@CR6]\]  Age at menopause1021,44949--51 vs \<48OR 0.9 (0.7--1.3)\[[@CR20]\]≥52 vs \<48OR 1.1 (0.8--1.5)  Age at menarche1021,44912--13 vs \<11OR 0.8 (0.6--1.0)\[[@CR20]\]≥14 vs \<11OR 1.0 (0.8--1.3)Comorbidity  Urinary incontinence21649UI surgery vs noOR 2.2 (0.9--5.4)\[[@CR6]\]12,650Stress UI vs neverHR 1.1 (1.0--1.3)\[[@CR21]\]Urge UI vs neverHR 1.3 (1.1--1.5)\*Mixed UI vs neverHR 1.2 (1.0--1.5)\*Other UI vs neverHR 1.0 (0.8--1.4)  Pulmonary disease20270Asthma yes vs noNS^b,c^\[[@CR15]\]12,650AsthmaHR 1.0 (0.8--1.2)\[[@CR21]\]EmphysemaHR 1.2 (0.9--1.6)  Constipation201,004Yes vs noNS^c,d^\[[@CR13]\]12,650Moderate/severe vs noHR 1.0 (0.8--1.2)\[[@CR21]\]  Diabetes111,137Yes vs noPR 1.1 (1.1--1.1)\*\[[@CR16]\]  Chronic illness101,004Any vs noneOR 1.1 (0.5--2.1)^c^\[[@CR13]\]  Hysterectomy status101,004Yes vs noOR 1.1 (0.7--1.6)^c^\[[@CR13]\]  Previous hernia surgery10270Yes vs noNS^b,c^\[[@CR15]\]  POP in pregnancy10649Yes vs noOR 1.4 (1.0--2.1)\[[@CR6]\]Social factors  Education4221,449Intermediate school vs elementaryOR 0.6 (0.5--0.8)\*\[[@CR20]\]High school/university vs elementaryOR 0.6 (0.4--0.8)\*270≤High school vs \> high schoolOR 2.2 (1.1--4.2)\*\[[@CR15]\]1,137≥College vs \< collegePR 1.0 (1.0--1.1)\[[@CR16]\]649Intermediate school vs unknownOR 0.7 (0.4--1.1)\[[@CR6]\]  Occupation20270Previous employment historyNS^b,c^\[[@CR15]\]1,004Labor vs nonlaborOR 1.2 (0.6--2.3)^c^\[[@CR13]\]  Income111,004Medium vs highOR 0.3 (0.1--0.8)\*\[[@CR13]\]Low vs highOR 1.4 (0.5--3.9)Pelvic floor factors  Levator defect11605Unilateral vs no avulsionOR 2.8 (1.4--5.4)\*\[[@CR14]\]Bilateral vs no avulsionOR 4.0 (1.8--9.1)\*  Hiatus genitalis11605Hiatal area on Valsalva per cm^2^OR 1.1 (1.1--1.1)\*\[[@CR14]\]*HRT* hormone replacement therapy,*E + P * estrogen plus progesterone, *UI* urinary incontinence,*POP* pelvic organ prolapse\*Statistically significant association (*p* \< 0.05)^a^In some studies hazard ratio or prevalence ratio was used^b^No other data in article^c^Data of univariate analysis, not in multivariate analysis^d^Described in article twice with different results, both not significant

Risk factors for POP recurrence {#Sec5}
-------------------------------

The articles investigating potential risk factors for prolapse recurrence are listed in Table [4](#Tab4){ref-type="table"}. Of the 5 articles included, 3 were prospective cohort studies and 2 were retrospective cohort studies. Overall, the quality of the studies included was assessed as adequate: all studies had clear participant recruitment and selection criteria; the outcome and covariates were clearly defined; results were well presented; median follow-up after surgery was between 1 and 12 years. However, selective loss to follow-up could not be excluded in 1 study, in which less than half of the women included had attended the follow-up visit and no comparisons were reported between women attending the follow-up visit and women not attending the follow-up visit \[[@CR22]\]. In 4 out of 5 studies the number of risk factors evaluated was higher than generally advised (i.e., 10 events per candidate variable) \[[@CR12], [@CR23]--[@CR26]\]. For example, 1 study had 36 events (i.e., prolapse recurrence) and assessed 10 candidate variables \[[@CR23]\], and another study had 42 events and assessed 12 candidate variables \[[@CR24]\]. In 1 study it was explicitly described that the examining physician was blinded to other data, such as a questionnaire or ultrasound findings \[[@CR25]\].Table 4Articles on prolapse recurrence includedReferenceStudy type*N*/*n*Inclusion criteriaFollow-upRisk factorsTegerstedt and Hammarstrom \[[@CR26]\]Retrospective cohort study128/56Women who had prolapse surgery (Manchester procedure, anterior colporrhaphy, posterior colporrhaphy, cervix amputation, vaginal hysterectomy, enterocele repair, abdominal vaginosacropexy or combinations)10--12 yearsAge, preoperative stage, BMI, pulmonary disease, smoking, urinary incontinence, complicated delivery, previous pelvic floor surgery, heavy lifting, incomplete emptying of bladder, constipation, fecal incontinence, surgeon's experienceWhiteside et al \[[@CR22]\]Prospective cohort study176/102Women who underwent anterior colporrhaphy, with or without hysterectomy, posterior colporrhaphy, bladder neck plication, vaginal vault suspension, enterocele repair, culdoplasty, bladder neck suspension or retropubic paravaginal defect repair1 yearAge, preoperative stage, hysterectomy status, number of sites involved, urinary incontinence, previous prolapse surgery, menopausal status, diabetes, site of most advanced preoperative prolapse, previous incontinence surgeryDiez-Itza et al \[[@CR24]\]Retrospective cohort study134/42Women who had vaginal hysterectomy, anterior colporrhaphy or posterior colporrhaphy for prolapse5 yearsAge, preoperative stage, BMI, constipation, pulmonary disease, parity, family history, surgeon's experience, weight, abdominal hernias, intense physical exercise, levator muscle contractionSalvatore et al \[[@CR23]\]Prospective cohort study360/36Women who underwent prolapse surgery without using grafts (vaginal hysterectomy, and/or anterior colporrhaphy and/or posterior colporrhaphy)26 monthsAge, preoperative stage, BMI, constipation, hysterectomy status, pulmonary disease, parity, genital hiatus, menopausal status, birth weightWeemhoff et al \[[@CR25]\]Prospective cohort study156/80Women who underwent anterior colporrhaphy, with or without hysterectomy, posterior colporrhaphy or sacrospinous fixation2 yearsAge, preoperative stage, BMI, constipation, parity, number of sites involved, family history, concomitant surgery, previous prolapse surgery, complicated delivery, levator defect*N*/*n* number of women included in the study who underwent physical examination/number of women with pelvic organ prolapse recurrence

The 5 articles included enrolled a total of 954 women of which 316 with POP recurrence. POP recurrence was defined as POPQ stage 2 or more in all studies.

In the 5 articles, 29 potential risk factors were investigated, of which 8 were significantly associated at least once with POP recurrence after surgery in the multivariate analysis (Table [5](#Tab5){ref-type="table"}).Table 5Risk factors for prolapse recurrenceRisk factorTimes investigatedTimes statistically significant*N*DefinitionAdjusted OR (95 % CI)ReferenceObstetric factors  Parity301340 vs ≥1NS^a^\[[@CR24]\]360Per 1NS^a^\[[@CR23]\]156Per 1OR 0.9 (0.7--1.2)^b^\[[@CR25]\]  Complicated delivery20128Yes vs noOR 1.4 (0.9--1.9)^b^\[[@CR26]\]156Assisted vs noOR 0.8 (0.3--2.1)^b^\[[@CR25]\]  Birth weight10360\>4,000 g vs ≤4,000 gOR 1.8 (0.9--3.6)^b^\[[@CR23]\]  Age at last delivery10134Per 1NS^a^\[[@CR24]\]Lifestyle factors  BMI40128\>25 vs ≤25OR 1.2 (0.9--1.8)^b^\[[@CR26]\]134Per kg/m^2^NS^a^\[[@CR24]\]360\>30 vs ≤30OR 1.2 (0.5--2.8)^b^\[[@CR23]\]156Per kg/m^2^OR 1.0 (0.9--1.1)^b^\[[@CR25]\]  Weight11134\>65 vs ≤65OR 4.0 (1.6--9.6)\*\[[@CR24]\]  Intense physical exercise10134Yes vs noNS^a^\[[@CR24]\]  Heavy lifting10128Yes vs noOR 1.1 (0.7--1.6)^b^\[[@CR26]\]  Smoking10128Yes vs noOR 1.4 (0.8--2.5)^b^\[[@CR26]\]Unmodifiable factors  Age52128\>70 vs ≤70NS^a^\[[@CR26]\]176\<50 vs 50--59 vs 60--69 vs ≥70 \<60 vs ≥60NS^a^\
OR 3.2 (1.6--6.4)\*\[[@CR22]\]134\<60 vs ≥60OR 4.1 (1.6--10.4)\*\[[@CR24]\]360Age per yearNS^a^\[[@CR23]\]156Age per yearNS^a^\[[@CR25]\]  Family history21134Yes vs noNS^a^\[[@CR24]\]156Yes vs noOR 2.4 (1.2--4.9)\*\[[@CR25]\]  Menopausal status20176Yes vs noNS^a^\[[@CR22]\]360Yes vs noNS^a^\[[@CR23]\]Comorbidity  Constipation40128Yes vs noOR 1.1 (0.7--1.7)^b^\[[@CR26]\]134Yes vs noNS^a^\[[@CR24]\]360Yes vs noOR 0.6 (0.3--1.4)^b^\[[@CR23]\]156Yes vs noOR 1.0 (0.4--2.3)^b^\[[@CR25]\]  Previous pelvic floor surgery31128Yes vs noOR 1.8 (1.1--2.8)^b^\*\[[@CR26]\]176Yes vs noNS^a^\[[@CR22]\]156Yes vs noOR 1.4 (0.5--4.0)^b^\[[@CR25]\]  Pulmonary disease30128Yes vs noOR 1.3 (0.7--2.4)^b^\[[@CR26]\]134Yes vs noNS^a^\[[@CR24]\]360Yes vs noOR 1.6 (0.7--3.8)^b^\[[@CR23]\]  Any incontinence preoperative21128Yes vs noOR 1.4 (1.0--2.1)^b^\*\[[@CR26]\]176Yes vs noNS^a^\[[@CR22]\]  Previous hysterectomy20176Yes vs noNS^a^\[[@CR22]\]360Yes vs noOR 0.6 (0.3--1.2)^b^\[[@CR23]\]  Incomplete emptying of bladder10128Yes vs noOR 1.3 (0.9--1.9)^b^\[[@CR26]\]  Fecal incontinence10128Yes vs noNS^a^\[[@CR26]\]  Diabetes10176Yes vs noNS^a^\[[@CR22]\]  Abdominal hernias10134Yes vs noNS^a^\[[@CR24]\]Surgical factors  Preoperative stage54128Stage IV vs \< stage IVOR 1.5 (0.9--2.4)\[[@CR26]\]176Stage III or IV vs stage IIOR 2.7 (1.3--5.3)\*\[[@CR22]\]134Stage III or IV vs stage I or IIOR 3.9 (1.2--13.0)\*\[[@CR24]\]360Stage III or IV vs stage I or IIOR 2.4 (1.1--5.1)\*\[[@CR23]\]156Stage III or IV vs stage I or IIOR 2.0 (1.0--4.1)\*\[[@CR25]\]  Surgeon's experience20128Senior vs no senior surgeonOR 0.8 (0.5--1.3)^b^\[[@CR26]\]134Junior vs no junior surgeonNS^a^\[[@CR24]\]  Number. of sites involved preoperative201761 vs 2 vs 3NS^a^\[[@CR22]\]1562 vs 1\
3 vs 1OR 1.1 (0.5--2.5)^b^\
OR 0.7 (0.3--1.8)^b^\[[@CR25]\]  Concomitant surgery11156Sacrospinal fixation vs noOR 6.5 (2.0--21.2)\*\[[@CR25]\]Pelvic floor factors  Levator defect11156Yes vs noOR 2.3 (1.1--4.8)\*\[[@CR25]\]  Hiatus genitalis10360UnknownOR 1.4 (0.5--2.3)^b^\[[@CR23]\]  Levator muscle contraction10134Oxford scale \<3 vs ≥3NS^a^\[[@CR24]\]  Site of most advanced prolapse10176Anterior vs apex vs posteriorNS^a^\[[@CR22]\]\*Statistically significant association (*p *\< 0.05)^a^No other data in article^b^Data of univariate analysis, not in multivariate analysis

Risk factors discussed by topic {#Sec6}
-------------------------------

### Obstetric factors {#Sec7}

Parity and vaginal delivery were frequently investigated and shown to be risk factors for primary POP \[[@CR15], [@CR16], [@CR18]--[@CR21]\], except in 2 studies \[[@CR6], [@CR13]\]. The association with cesarean delivery was less clear. While in 2 studies no association between cesarean delivery and primary POP was found \[[@CR19], [@CR20]\], 1 study showed that cesarean delivery was a risk factor when compared with nulliparous women \[[@CR16]\], and 2 studies found that it was protective when compared with spontaneous or operative vaginal delivery \[[@CR17], [@CR18]\]. There was a trend toward an association between larger birth weight and primary POP, but only in 1 out of 3 studies was this statistically significant \[[@CR13], [@CR15], [@CR20]\]. Higher age at first delivery was a risk factor in 1 study \[[@CR18]\], but in another study no significant association was found \[[@CR15]\]. Operative vaginal delivery, age at last delivery, and gravidity were investigated only once and no significant associations were found, except for forceps delivery, which was protective against primary POP when compared with spontaneous vaginal delivery only \[[@CR13], [@CR15], [@CR18]\].

For POP recurrence, parity and complicated delivery were not significant risk factors \[[@CR23]--[@CR25]\]. This was in contrast with primary POP, for which parity was a risk factor. This phenomenon might be because in studies concerning POP recurrence, only women with a primary POP are included; therefore, this is a selected group of women. Birth weight and age at last delivery were only investigated once and no significant association was found \[[@CR23], [@CR24]\].

### Lifestyle factors {#Sec8}

Higher body mass index (BMI) as a categorical variable was a significant risk factor for primary POP \[[@CR13], [@CR16], [@CR20], [@CR21]\], except for the 2 studies with the smallest sample sizes \[[@CR15], [@CR18]\]. Two studies investigated BMI as a continuous variable, of which 1 found no association \[[@CR6]\] and in contrast with the other studies, 1 found that a higher BMI was slightly protective \[[@CR19]\]. Waist circumference and use of hormone replacement therapy were each only once significantly associated with primary POP; thus, no conclusion can be drawn \[[@CR13], [@CR15], [@CR21]\]. The results for the relation between smoking and primary POP were inconsistent. One study showed a trend toward a positive association \[[@CR20]\], while in 3 studies smoking was protective \[[@CR6], [@CR19], [@CR21]\], and in 2 studies no association was found \[[@CR13], [@CR15]\]. One study argued that there might be an association between cigarette smoking and POP because smoking causes chronic respiratory diseases and higher abdominal pressure, but a negative association was found because smoking seemed to be linked to factors such as age and menopausal status \[[@CR19]\]. This hypothesis was supported by the fact that in another study the seemingly protective effect disappeared in the multivariate analysis \[[@CR13]\]. Physical activity was not a significant risk factor for primary POP \[[@CR6], [@CR15], [@CR21]\].

Although higher BMI was a risk factor for primary POP, it was not a significant risk factor for POP recurrence \[[@CR23]--[@CR26]\]. Weight, intense physical exercise, heavy lifting, and smoking were examined only once and only weight was significantly associated with POP recurrence, but no firm conclusions can be drawn owing to a lack of confirmation \[[@CR24], [@CR26]\].

### Unmodifiable factors {#Sec9}

Age was a risk factor for primary POP \[[@CR13], [@CR16], [@CR20], [@CR21]\], except in the 2 smallest studies \[[@CR6], [@CR15]\]. The role of ethnicity remained unclear in relation to primary POP. In 1 study a higher risk in Hispanic women compared with white women was found, while in another study there was no significant association \[[@CR13], [@CR21]\]. Another study found a higher risk in white women compared with black women, while 2 other studies found no association \[[@CR13], [@CR16], [@CR21]\]. Menopausal status showed a trend toward a positive association with primary POP, but in only 1 of the 3 studies was it a significant risk factor \[[@CR6], [@CR13], [@CR19]\]. Family history was not a significant risk factor \[[@CR6], [@CR15]\]. Age at menopause and age at menarche were only examined once and showed no association \[[@CR20]\].

Age as a risk factor for POP recurrence showed inconsistent results. In 2 studies, in which age was categorized as below 60 years compared with 60 years or older, younger age was a significant risk factor for POP recurrence after surgery \[[@CR22], [@CR24]\]. In 2 studies in which age was a continuous variable and in 1 study in which age was categorized as older than 70 years compared with 70 years or younger, no significant associations were found \[[@CR23], [@CR25], [@CR26]\]. With regard to family history, 1 study found a significant association while another found no significant association \[[@CR24], [@CR25]\]. Menopausal status was not significantly associated with POP recurrence \[[@CR22], [@CR23]\].

### Comorbidity {#Sec10}

Constipation and pulmonary disease were not significantly associated with primary POP \[[@CR13], [@CR15], [@CR21]\]. Urge and mixed urinary incontinence showed a significant association, while urinary incontinence surgery, stress urinary incontinence, and other forms of urinary incontinence were not significantly associated with primary POP \[[@CR6], [@CR21]\]. Diabetes mellitus, chronic illness, hysterectomy status, previous hernia surgery, and POP in pregnancy were examined once and only diabetes mellitus was significantly associated with primary POP \[[@CR13], [@CR15], [@CR16], [@CR21]\]. Owing to a lack of confirmation, no firm conclusions can be drawn.

Regarding POP recurrence, previous pelvic floor surgery and any preoperative urinary incontinence showed inconsistent results \[[@CR22], [@CR25], [@CR26]\]. Constipation, pulmonary disease, and previous hysterectomy were not significant risk factors \[[@CR22]--[@CR26]\]. Incomplete bladder emptying, fecal incontinence, diabetes mellitus, and abdominal hernias were only investigated once and no significant associations were found \[[@CR22], [@CR24], [@CR26]\]. Owing to a lack of confirmation, no firm conclusions can be drawn.

### Social factors {#Sec11}

Having less education was a significant risk factor for primary POP in 2 out of 4 studies, while occupation was not significantly related \[[@CR6], [@CR13], [@CR15], [@CR16], [@CR20]\]. Income was only investigated once \[[@CR13]\]. Women with a medium income were less likely to have POP compared with women with a high income, while the number of women with POP in the low income group was not significantly different from the number of women in the high income group.

The relation between social factors and POP recurrence was not evaluated in the 5 articles selected.

### Pelvic floor factors {#Sec12}

With regard to primary POP, levator defects and the genital hiatus on transperineal ultrasound were investigated as risk factors in 1 article \[[@CR14]\]. Both a unilateral and a bilateral avulsion compared with no avulsion were significant risk factors for primary POP. An increased hiatal area on Valsalva was also associated with primary POP. For POP recurrence, levator defects, the site of most advanced prolapse, the genital hiatus on pelvic floor examination, and levator muscle contraction on pelvic floor examination were examined in 1 report, and only levator defects were significantly associated with POP recurrence \[[@CR22]--[@CR25]\]. Because of a lack of confirmative studies, no clear conclusion can be drawn.

### Surgical factors {#Sec13}

In 4 studies, preoperative stage 3 or 4 was a significant risk factor for POP recurrence after surgery \[[@CR22]--[@CR25]\]. Only the study in which preoperative stage 4 was compared with a preoperative stage of less than 4 found no significant association \[[@CR26]\]. The number of sites involved preoperatively and the surgeon's experience were not significant risk factors for POP recurrence \[[@CR22], [@CR24]--[@CR26]\]. Concomitant surgery was examined in 1 article and a sacrospinous fixation was a significant risk factor for POP recurrence \[[@CR25]\].

Discussion {#Sec14}
==========

This systematic review provides an overview of the risk factors affecting the development of POP and POP recurrence after native tissue repair, investigated in cohort studies and cross-sectional studies. With regard to primary POP, parity, vaginal delivery, age, and BMI were the most important risk factors. Regarding POP recurrence, only preoperative stage was a confirmed risk factor.

The differences between risk factors for primary POP and POP recurrence might be explained by the differences in population. In studies concerning POP recurrence, only women with a primary POP are included; thus, this is a selected group of women. For instance, higher age was a risk factor for primary POP. If a woman obtained POP at a younger age, she might be more prone to POP recurrence after surgery than an older woman with POP, because of hereditary factors or connective tissue weakness. Indeed, the studies investigating the association between age and POP recurrence showed conflicting results. Perhaps the association between age and POP recurrence is not linear but parabolic, with both younger age and higher age being risk factors for POP recurrence. This is difficult to prove, but could explain the conflicting results. Other causes of the differences in confirmed risk factors for primary POP and POP recurrence might have been the smaller number of studies and the smaller sample sizes in the evaluation of risk factors for POP recurrence.

In the prevention of primary POP, BMI was the only modifiable risk factor. Theoretically, parity and vaginal delivery are also modifiable, but in obstetric care future POP seldom plays a role in considerations. With regard to preoperative counselling, only preoperative stage was a confirmed risk factor in the estimation of the chance of POP recurrence. The role of other patients\' or surgeons' characteristics was not confirmed.

There were several strengths and limitations of this review. The search was thorough and systematic. Two reviewers independently carried out the study selection and data extraction to minimize errors. Potential risk factors for both primary POP and POP recurrence were studied. We extracted the results of the multivariate analyses; thus, the reported effects were adjusted for potentially confounding variables. Studies with follow-up after surgery of less than 1 year were excluded to avoid bias due to surgical failures, which represents a different phenomenon than POP recurrence.

Only studies situated in western developed countries were included, because the population in developing countries may differ from that in developed countries. It has been stated that the prevalence of symptomatic POP among women in developing countries is higher than among women in developed countries, owing to early childbearing, high parity, low birth spacing, early return to work after delivery, poor birthing practices, frequent heavy lifting, and malnutrition \[[@CR27]\]. Many women do not seek medical attention because of embarrassment, social taboos, fear of abandonment, knowledge deficit, lack of resources, and lack of access to trained personnel \[[@CR28], [@CR29]\].

Recurrence of POP was defined as anatomical recurrence after native tissue repair, i.e., without the use of mesh materials. Native tissue repair is the standard method of POP surgery, while the use of mesh in POP surgery has become controversial \[[@CR30]\]. It is stated that the use of mesh should be reserved for high-risk individuals in whom the benefit of the use of mesh may justify the risks, such as individuals with recurrent POP \[[@CR31]\]. The population in studies on POP recurrence after mesh surgery often consists of a selected, high-risk group of women, which cannot be compared with the population in studies on POP recurrence after native tissue repair.

Systematic reviews of prognostic studies are complicated by several issues, which have been well described by Altman \[[@CR32]\]. Two major concerns are the quality of the primary studies and the possibility of publication bias. Although there is abundant literature to help researchers perform this type of research, there are still no widely agreed guidelines for assessing the quality of prognostic studies and there is no standard approach to building a multivariate prediction model \[[@CR33]\]. Clear guidelines on the assessment of the quality of this type of study would be helpful.

Because of the enormous amount of available articles and variables studied on this subject, we were forced to select the papers providing the strongest evidence. We decided to exclude case--control studies because they are more prone to selection bias and often contain a smaller sample size than cohort or cross-sectional studies. Risk factors that have only been examined in case--control studies, such as collagen and matrix metalloproteinase polymorphisms, have been missed owing to this strategy.

Even after exclusion of case--control studies there was heterogeneity among the available studies. For example, the definitions of primary POP and the definitions of risk factors varied widely between studies, diverse covariates were used in multivariate analyses, and in the studies on POP recurrence there was diversity among the surgery performed. Because of this heterogeneity, it was not possible to perform a meta-analysis to pool the available results into reliable risk ratios. For uniformity, only articles were included with a definition of POP based on anatomical references such as the hymenal remnants or POPQ stage 2. POP recurrence was defined as anatomical recurrence after surgery, but this does not equate to recurrence or persistence of symptoms, which would have been a more patient-centered outcome \[[@CR34]\]. Many women who may be categorized as "anatomical failures" are, in fact, satisfied with their postsurgical results \[[@CR35]\]. The problem with studies using only subjective findings for the definition of POP recurrence is that it is not possible to differentiate between the recurrence of POP in the same operated vaginal compartment and that in a different one \[[@CR11]\]. That is why only studies in which pelvic floor examination was performed were included in this review. Uniformly accepted criteria for the definition of a successful POP operation are still lacking \[[@CR36]\].

Furthermore, there are inconsistencies among studies as to whether a potential risk factor was indeed significantly associated with the primary outcome. Some potential risk factors were even protective against the primary outcome in one study, while they were a risk factor for that same outcome in another study. This made it difficult to come to conclusions. That is why we confirmed as risk factors only those that were significantly associated with POP or POP recurrence in at least two studies. Consequently, risk factors that have only been studied once and were significantly associated with POP or POP recurrence were not described as confirmed risk factors.

In conclusion, this systematic review showed that parity, vaginal delivery, age, and BMI were confirmed risk factors for the development of POP and that preoperative stage was a confirmed risk factor for POP recurrence after native tissue repair in western developed countries.

Appendix A1: full PubMed literature search terms {#Sec15}
================================================

((((pelvic prolapse\[tiab\] OR pelvic prolapses\[tiab\] OR ((((prolapse\[tiab\] OR prolapses\[tiab\]) AND (urogenital\[tiab\] OR genital\[tiab\] OR vaginal\[tiab\] OR pelvic organ\[tiab\]) OR cystocele\[tiab\] OR cystoceles\[tiab\] OR urinary bladder prolapse\[tiab\] OR urinary bladder prolapses\[tiab\])) OR rectocele OR rectoceles OR (\"Pelvic Organ Prolapse\"\[Mesh\])))) AND (((((\"Recurrence\"\[Mesh\])) OR (recurrence\[tiab\] OR recurrences\[tiab\] OR recurrent\[tiab\] OR relapse\[tiab\] OR relapses\[tiab\]))) OR (relapsing\[tiab\])))) OR (((\"Risk Factors\"\[Mesh\] OR risk\[tiab\] OR risks\[tiab\] OR \"risk factor\"\[tiab\] OR \"risk factors\"\[tiab\] OR "predict"\[tiab\] OR "predicts"\[tiab\] OR "prediction"\[tiab\] OR "predictions"\[tiab\] OR "predictive"\[tiab\] OR "predicting"\[tiab\])) AND ((\"Pelvic Organ Prolapse\"\[Mesh\]) OR ((prolapse\[tiab\] OR prolapses\[tiab\]) AND (urogenital\[tiab\] OR genital\[tiab\] OR vaginal\[tiab\] OR pelvic organ\[tiab\] OR pelvic\[tiab\]) OR cystocele\[tiab\] OR cystoceles\[tiab\] OR urinary bladder prolapse\[tiab\] OR urinary bladder prolapses\[tiab\])))

Appendix A2: full Embase literature search terms {#Sec16}
================================================

((((pelvic prolapse\[tiab\] OR pelvic prolapses\[tiab\] OR ((((prolapse\[tiab\] OR prolapses\[tiab\]) AND (urogenital\[tiab\] OR genital\[tiab\] OR vaginal\[tiab\] OR pelvic organ\[tiab\]) OR cystocele\[tiab\] OR cystoceles\[tiab\] OR urinary bladder prolapse\[tiab\] OR urinary bladder prolapses\[tiab\])) OR rectocele OR rectoceles OR (\"Pelvic Organ Prolapse\"\[Mesh\])))) AND (((((\"Recurrence\"\[Mesh\])) OR (recurrence\[tiab\] OR recurrences\[tiab\] OR recurrent\[tiab\] OR relapse\[tiab\] OR relapses\[tiab\]))) OR (relapsing\[tiab\])))) OR (((\"Risk Factors\"\[Mesh\] OR risk\[tiab\] OR risks\[tiab\] OR \"risk factor\"\[tiab\] OR \"risk factors\"\[tiab\] OR "predict"\[tiab\] OR "predicts"\[tiab\] OR "prediction"\[tiab\] OR "predictions"\[tiab\] OR "predictive"\[tiab\] OR "predicting"\[tiab\])) AND ((\"Pelvic Organ Prolapse\"\[Mesh\]) OR ((prolapse\[tiab\] OR prolapses\[tiab\]) AND (urogenital\[tiab\] OR genital\[tiab\] OR vaginal\[tiab\] OR pelvic organ\[tiab\] OR pelvic\[tiab\]) OR cystocele\[tiab\] OR cystoceles\[tiab\] OR urinary bladder prolapse\[tiab\] OR urinary bladder prolapses\[tiab\])))
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